Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Ibrutinib

Leukocytoclastic vasculitis

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Kaya A, et al. Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia. Turkish Journal of Haematology 41: 57-58, Jan 2024 Kaya A, et al. Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia. Turkish Journal of Haematology 41: 57-58, Jan 2024
Metadaten
Titel
Ibrutinib
Leukocytoclastic vasculitis
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55607-z

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Antipsychotics

Case report

Multiple drugs

Case report

Prednisolone

Case report

Minoxidil